Trending
Oracle reports earnings next week with analysts pointing to upbeat pricing trends as a key tailwind. Here’s what to watch in the results.
OPEC+ is set to leave its October oil output policy unchanged at Sunday’s meeting, as the group must first finalize member quotas before setting new production targets.
Broadcom stock dipped after strong fiscal Q3 results, even as the company targets 400% AI revenue growth over two years. Here’s what investors should weigh.
A federal judge extended a block on Trump’s executive order regulating mail ballots Friday, keeping restrictions off the table as 2026 midterm planning proceeds.
Adobe named Anil Chakravarthy as next CEO, but shares fell after a senior executive departure raised concerns about broader leadership turnover.
Norway’s $2.3 trillion sovereign wealth fund has proposed significantly cutting its U.S. Treasury holdings to improve bond portfolio returns, per a letter published this week.
OPEC+ is set to leave its October oil output policy unchanged at Sunday’s meeting, as the group must first finalize member quotas before setting new production targets.
Norway’s $2.3 trillion sovereign wealth fund has proposed significantly cutting its U.S. Treasury holdings to improve bond portfolio returns, per a letter published this week.
Just In
Oracle reports earnings next week with analysts pointing to upbeat pricing trends as a key tailwind. Here’s what to watch in the results.
A federal judge allowed J.M. Smucker’s lawsuit against Trader Joe’s to proceed over frozen sandwiches Smucker says are too similar to its Uncrustables brand.
Ontario Premier Doug Ford responded to Trump’s “Lake America” push with a giant shoreline sign reading “Lake Ontario. Now and Always,” escalating U.S.-Canada tensions.
Finance
Broadcom stock dipped after strong fiscal Q3 results, even as the company targets 400% AI revenue growth over two years. Here’s what investors should weigh.
Editor's Picks
Amazon pays no dividend and dilutes shareholders, yet its interlocking Prime ecosystem, AWS, and ad business make a strong case for long-term holders.
Latest
Moderna stock has surged 127%, driven by its mRNA cancer vaccine program with Merck. But the valuation may already reflect success that is years away.
